Nina Niu Sanford/utswmed.org
Jun 5, 2025, 14:31
Nina Niu Sanford: 2 Additional Thoughts on the CHALLENGE Trial from ASCO 2025
Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post on X:
“2 additional thoughts regarding CHALLENGE trial as I return to clinic:
What level of evidence should be required before implementing an exercise program into cancer survivorship? Do we *need* a large RCT demonstrating a whopping OS improvement? Particularly in context of prior studies suggesting many mental, physical benefits to exercise (and with low/no toxicity)? There are plenty of other ancillary support services we pay for in oncology – nutritional counseling, social work, etc – do they have corresponding RCTs showing survival benefit?
I would also like to see a formal cost breakdown of the trial exercise program. Many are surmising it would be massive, but actual #s would help. May inform Q1 above, plus place into context with other therapies and services we currently sponsor.”
Read OncoDaily’s Special Articles about ASCO 2025:
Highlights from ASCO 2025 Day 1
Highlights from ASCO 2025 Day 2
Highlights from ASCO 2025 Day 3
Highlights from ASCO 2025 Day 4
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 17:54
Jun 26, 2025, 17:47
Jun 26, 2025, 17:29
Jun 26, 2025, 14:50
Jun 26, 2025, 14:20